Notes
NDEA = N-nitrosodiethylamine
CEP is a certificate of compliance with European standards for quality testing.
Also see Reactions 1711 p2; 803335025, see Reactions 1715 p1; 803341056, see Reactions 1717 p3; 803343140 and see Reactions 1725 p1; 803353257
Reference
European Medicines Agency. Valsartan from Mylan laboratories in India can no longer be used in EU medicines due to NDEA impurity. Internet Document : [2 pages], 19 Nov 2018. Available from: URL: https://www.ema.europa.eu/en/news/valsartan-mylan-laboratories-india-can-no-longer-be-used-eu-medicines-due-ndea-impurity
Rights and permissions
About this article
Cite this article
Mylan's valsartan products banned from EU medicines. Reactions Weekly 1730, 2 (2018). https://doi.org/10.1007/s40278-018-54902-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-54902-8